Materialise
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 2.4K
- Market Cap
- -
- Introduction
Materialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Long-term Safety and Performance of Materialise's Patient-specific TMJ System.
- Conditions
- Temporomandibular Joint Disorders
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Materialise
- Target Recruit Count
- 30
- Registration Number
- NCT06951178
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark
Long-term Safety and Performance of CMF Porous Titanium Implants
- Conditions
- Craniofacial Defects
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Materialise
- Target Recruit Count
- 200
- Registration Number
- NCT06910033
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇫🇷Hôpital Pitié-Salpêtrière, Paris, France
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
- Conditions
- Arthroplasty, Replacement, ShoulderGlenoid CavityOsteoarthritis of the Shoulder
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Materialise
- Target Recruit Count
- 24
- Registration Number
- NCT03806881
- Locations
- 🇧🇪
AZ St-Elisabeth, Herentals, Belgium
🇧🇪University Hospital Leuven - Traumatology, Leuven, Belgium
🇧🇪University Hospital Leuven - Orthopedics, Leuven, Belgium
Materialise X-ray Knee Guides for Total Knee Arthroplasty
- Conditions
- ArthroplastyKneeReplacement
- First Posted Date
- 2016-03-21
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- Materialise
- Target Recruit Count
- 3
- Registration Number
- NCT02713906
- Locations
- 🇧🇪
AZ Heilige Familie, Reet, Belgium
Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides
- Conditions
- Osteoarthritis, Hip
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Materialise
- Target Recruit Count
- 7
- Registration Number
- NCT02499523
- Locations
- 🇧🇪
AZ Monica, Antwerpen, Belgium
News
FDA Clinical Trial Launches for Revolutionary 3D-Printed Airway Device to Treat Infant Breathing Disorder
Michigan Medicine and Materialise initiate an eight-year clinical trial to evaluate 3D-printed bioresorbable airway splints for treating severe tracheobronchomalacia in infants, marking a crucial step toward FDA approval.